Japan's Pharma Majors Invest $525 Million in API-Related Projects
Japan's Pharma Majors Invest $525 Million in API-Related Projects
Attachment: Japan API 1121
KOFU, JAPAN--November 5, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Many Japanese pharmaceutical majors are expanding their active pharmaceutical ingredient (API) production facilities to produce new COVID-19 vaccines. In addition, they are at work on more typical maintenance, plant-expansion, equipment-upgrade and equipment-replacement projects.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Suffolk Construction Has Hand in $1.9 Billion Worth of Projects
- U.S. Home to Billions' Worth of 2Q ESG Project Kickoffs
- Japan Hosts $832 Million in CDMO/CMO-Related Pharma Projects
- Turner Construction Involved in More than $24 Billion Worth of U.S. Project...
- Medical Devices & Equipment Sector Brings Billions in Spending to the U.S.
Quick Links
- Home
- About Us
- Contact Us
- For Traders
Global Market Intelligence
- GMI Database Platform
- GMI Platform Tools
- Industry Coverage
- Analytics & Insights
- Advertising
